• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Coeptis Therapeutics Hldgs Inc (NQ: COEP )

    0.3114 -0.0235 (-7.02%)
    Streaming Delayed Price Updated: 3:58 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 202,006
    Open 0.3168
    Bid (Size) 0.3100 (2)
    Ask (Size) 0.3450 (5)
    Prev. Close 0.3349
    Today's Range 0.3075 - 0.3199
    52wk Range 0.2851 - 1.850
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    COEP Stock Earnings: Coeptis Therapeutics Beats EPS for Q4 2023
    COEP stock results show that Coeptis Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    -59.46%
    -59.46%
    1 Month
    +5.56%
    +5.56%
    3 Month
    -46.40%
    -46.40%
    6 Month
    -74.16%
    -74.16%
    1 Year
    -74.89%
    -74.89%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Biotech Innovation: Coeptis Therapeutics (COEP) And 3 Companies Changing The Game
    Via Get News
    Biotech Bright Spots: Coeptis Therapeutics (COEP) And 3 Hidden Treasures
    Via Get News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    These are the 4 hottest stocks insiders bought in January
    Via MarketBeat
    Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    How the Internet Turned Us Into Horrible Investors
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
    Via Benzinga
    Potential acquisition of VyGen-Bio would Strengthen Coeptis Therapeutics (NASDAQ: COEP) oncology pipeline by obtaining exclusive, worldwide ownership rights to GEAR™ Platform
    Via Get News
    Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics (NASDAQ: COEP)
    Via Get News
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.